x
ServiziMenu principaleHome
You are here: Home > What we do > Past events > 2017 > 6th Arab and Southern European Countries Masterclass in Clinical Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

Description

Chairs: M.S. Aapro, CH - N. Pavlidis, GR
Co-chairs:
J. Gligorov, FR - S. Khatib, JO
Host Chair:
D. Papamichael, CY



This is a 3-days clinically oriented educational programme dedicated to medical, clinical and radiation oncologists, who wish to improve their skills in oncology. The programme focuses on breast, gynaecological, prostate, colorectal, lung cancers and on lymphomas and its covered by an international faculty of top experts.

The Masterclass offers:
• plenary lectures regarding state-of-the art clinical evaluation and treatments with reference to clinical guidelines concluding in take-home messages;
• clinical case presentations will be delivered by the participants in Tumor Board discussions as well as in divided small groups with the presence of the chairmen and the faculty;
• a self-assessment test based on multiple choice questionnaire, will be provided to participants on the last day of the Masterclass.

All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission.

AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical and clinical oncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast, gynaecological, lung, urological and gastrointestinal cancers. Spotlight sessions will facilitate compact update on elderly patients, head and neck, melanoma, non-Hodgkin’s lymphoma, soft tissue sarcoma, supportive care.


LEARNING OBJECTIVES
• Improve medical and radiation oncologists’ skills
• Practicing case discussion
• Deep focus on breast, gynaecological, prostate, lung and colorectal cancer, lymphomas.

TEACHING FORMAT
The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.


THE MASTERCLASS:
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on breast, gynaecological, lung, urological and gastrointestinal cancers

MAIN TOPICS
• Breast cancer
• Gynaecological cancer
• Lung cancer
• Urological cancer
• Gastrointestinal cancer
• Lymphomas

Held in collaboration with               Held under the auspices of the
Arab Medical Association Against Cancer (AMAAC)
                 

 

General information

GENERAL INFORMATION
Organising secretariat
Daniela Mengato
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464523
Fax: +39 02 85464545
Email: dmengato@eso.net

Applications
Alice Ciocchini

Ph: +39 02 85464529

Email: aciocchini@eso.net

 






Faculty list

FACULTY
M.S. Aapro, Breast Center, Genolier, CH
D. Arnold, CUF Hospitals Cancer Center, Lisbon, PT
H. Azim, Cairo University, Cairo Oncology Center, EG
H. Boussen, Institut Salah Azaiz (ISA), Tunis, TN
M.J. Cardoso, Champalimaud Foundation, Lisbon, PT
P. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
A. Constantinidou, Medical School,
University of Cyprus, Nicosia, CY
G. Curigliano, European Institute of Oncology, Milan, IT
R. Gaafar, National Cancer Institute, Cairo, EG
F. Geara, American University of Beirut, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Center, Amman, JO
H. Khaled, National Cancer Institute, Cairo, EG
S. Khatib, Arab Medical Association Against Cancer (AMAAC), Amman, JO
O. Michielin, Lausanne University Hospital – CHUV, CH
N. Mottet, University Jean Monnet, Saint Etienne, FR
R. Orecchia, European Institute of Oncology, Milan, IT
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
G. Pruneri, European Institute of Oncology, Milan, IT
R. Stahel, University Hospital Zurich, CH
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
J.B. Vermorken, Antwerp University Hospital, BE



Programme

 14 December

    Participants’ arrival and dinner                     

 

 15 December

8:00
  Registration
8:45   Welcome address 
BREAST CANCER SESSION
Chairs: J. Gligorov, FR - H. Azim, EG
 9:00   What the clinician needs to know from the breast pathologist 
G. Pruneri, IT
 9:20   Discussion
 9:30   Current controversies/challenges in breast surgery
M.J. Cardoso, PT 
 9:50   Discussion
 10:00   The role of radiotherapy in early and locally advanced breast cancer
R. Orecchia, IT    
 10:20   Discussion
 10:30   Coffee break
 11:00   Neoadjuvant/adjuvant chemotherapy and biological agents 
G. Curigliano, IT
 11:20   Discussion
 11:30   Neoadjuvant/ adjuvant endocrine therapy 
J. Gligorov, FR
 11:50   Discussion
 12:00   Management of HER2+ advanced breast cancer 
G. Curigliano, IT
12:20   Discussion
12:30   Management of triple-negative advanced breast cancer 
H. Azim, EG
12:50   Discussion
13:00   Management of ER+ advanced breast cancer
J. Gligorov, FR
13:20   Discussion
13:30   Lunch
 14:30   Breast Cancer Tumor Board (4 cases)
GYNECOLOGICAL CANCER SESSION
Chairs: A. Constantinidou, CY - J.B. Vermorken, BE                                                                                                                                                                                    
15:30   Systemic management of ovarian cancer
J.B. Vermorken, BE       
15:50   Discussion
16:00   Systemic management of locally advanced or metastatic cervical and endometrial cancer
J.B. Vermorken, BE 
16:20   Discussion
16:30   Coffee break
17:00   Gynecological  Cancer Tumor Board (4 cases)
 20:00   Dinner with faculty

 

 16 December

LUNG CANCER SESSION
Chairs: R. Stahel, CH - F. Geara, LB                
 8:30   The impact of radiation therapy in lung cancer 
F. Geara, LB 
8:50   Discussion
9:00   Neoadjuvant  and adjuvant systemic treatment in NSCLC
R. Gaafar, EG
9:20   Discussion
9:30   Systemic chemotherapy and targeted treatment in metastatic NSCLC  
R. Stahel, CH
9:50   Discussion
10:00   Immune check point inhibitors in NSCLC
R. Stahel, CH
10:20   Discussion
10:30   Coffee break
11:00
  Management of small-cell lung cancer
R. Gaafar, EG                                 
11:20
  Discussion
 11:30   Systemic management of advanced mesothelioma
R. Stahel, CH 
 11:50   Discussion
 12:00   Lung Cancer Tumor Board (4 cases) 
 13:00   Lunch
SPOTLIGHT SESSION 1
 14:00   Modern management of melanoma
O. Michielin, CH
 14:20   Discussion
 14:30   Update  in the management of head and neck cancer 
J.B. Vermorken, BE
 14:50   Discussion
 15:00   How do I manage cancer in elderly patients 
M.S. Aapro, CH
 15:20   Discussion
 15:30   Coffee break
16:00
  Parallel Group Sessions I  (Cases discussion in three Groups)
 20:00   Dinner with faculty

 

 17 December

UROLOGICAL CANCER SESSION
Chairs: H. Khaled, EG - N. Mottet, FR
8:30   Management including active surveillance of localized prostate cancer 
J. Khader, JO
8:55   Discussion
9:05   Key topics in locally advanced, advanced and metastatic prostate cancer
N. Mottet, FR
9:45   Discussion
10:00   Update in the management of bladder cancer
H. Khaled, EG
10:20   Discussion
10:30   Coffee break
11:00   Update in the management of renal cancer
N. Mottet, FR 
11:20   Discussion
11:30   Management of relapsed testicular cancer
H. Boussen, TN
 11:40   Discussion
12:00   Urological Cancer Tumor Board (4 cases)
13:00   Lunch

SPOTLIGHT SESION 2

 14:00   Supportive care 
M.S. Aapro, CH
 14:20   Discussion
14:30   Update in the management of soft tissue sarcomas
A. Constantinidou, CY
14:50   Discussion                  
15:00   Update in the management of high grade NHL 
A. Stathis, CH
15:20   Discussion
15:30   Coffee break
 16:00   Parallel Group Sessions II (Cases  discussion in three Groups)
 20:00   Dinner with faculty

 

 18 December

GASTROINTESTINAL CANCER SESSION
Chairs: D. Papamichael, CY - D. Arnold, PT 
 8:30   Adjuvant / neoadjuvant systemic treatment in colorectal  cancer 
D. Papamichael, CY
8:50   Discussion
 9:00   Systemic treatment in advanced colon cancer
D. Arnold, PT
 9:20   Discussion
 9:30   Radiation treatment in rectal cancer
J. Khader, JO 
9:50   Discussion
10:00   Systemic treatment in early and advanced gastric cancer
D. Arnold, PT
10:20   Discussion
10:30   Coffee break
11:00   Gastrointestinal Cancer Tumor Board (4 cases)
12:00   Learning Self-Assessment Test
13:15   Closing and  Departures